Andolong, Josephine A.

HRN: 28-69-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/15/2026
03/21/2026
IV
500MG
Q8H
OBSTRUCTIVE JAUNDICE PROB SEC TO HEPATOBILIARY PATHOLOGY; R/I HEPATITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: